Furthermore, TRIM3 exerts its inhibitory action by suppressing the expression of downstream target genes in the Wnt/β-catenin signaling pathway, such as c-Myc and CyclinD1, thus curtailing the proliferation and invasion of colorectal cancer cells (Song et al. 2019). This evidence concerns the gene TRIM3 and colorectal cancer.